Cite
HARVARD Citation
Xing, J. et al. (n.d.). SIRT4 enhances the sensitivity of ER‐positive breast cancer to tamoxifen by inhibiting the IL‐6/STAT3 signal pathway. Cancer medicine. pp. 7086-7097. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xing, J. et al. (n.d.). SIRT4 enhances the sensitivity of ER‐positive breast cancer to tamoxifen by inhibiting the IL‐6/STAT3 signal pathway. Cancer medicine. pp. 7086-7097. [Online].